GARS Antikörper (AA 60-370)
Kurzübersicht für GARS Antikörper (AA 60-370) (ABIN6140964)
Target
Alle GARS Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 60-370
-
Sequenz
- AEEVLAPLRL AVRQQGDLVR KLKEDKAPQV DVDKAVAELK ARKRVLEAKE LALQPKDDIV DRAKMEDTLK RRFFYDQAFA IYGGVSGLYD FGPVGCALKN NIIQTWRQHF IQEEQILEID CTMLTPEPVL KTSGHVDKFA DFMVKDVKNG ECFRADHLLK AHLQKLMSDK KCSVEKKSEM ESVLAQLDNY GQQELADLFV NYNVKSPITG NDLSPPVSFN LMFKTFIGPG GNMPGYLRPE TAQGIFLNFK RLLEFNQGKL PFAAAQIGNS FRNEISPRSG LIRVREFTMA EIEHFVDPSE KDHPKFQNVA D
-
Kreuzreaktivität
- Human, Maus, Ratte
-
Produktmerkmale
- Polyclonal Antibodies
-
Aufreinigung
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 60-370 of human GARS (NP_002038.2).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB,1:1000 - 1:4000,IHC,1:50 - 1:200,IF,1:50 - 1:200
-
Kommentare
-
HIGH QUALITY
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- GARS (Glycyl-tRNA Synthetase (GARS))
-
Andere Bezeichnung
- GARS
-
Hintergrund
- This gene encodes glycyl-tRNA synthetase, one of the aminoacyl-tRNA synthetases that charge tRNAs with their cognate amino acids. The encoded enzyme is an (alpha)2 dimer which belongs to the class II family of tRNA synthetases. It has been shown to be a target of autoantibodies in the human autoimmune diseases, polymyositis or dermatomyositis. Two transcript variants encoding different isoforms have been found for this gene.,GARS,CMT2D,DSMAV,GlyRS,HMN5,SMAD1,Epigenetics & Nuclear Signaling,Endocrine & Metabolism,Mitochondrial metabolism,GARS
-
Molekulargewicht
- 83 kDa
-
Gen-ID
- 2617
-
UniProt
- P41250
-
Pathways
- Ribonucleoside Biosynthetic Process
Target
-